Part 1 – Key Principles of Procedural Aspects
This first part of the course takes you inside the procedural foundations of the EU Clinical Trials Regulation (EU CTR). Step by step, you’ll learn how trials are assessed and coordinated across Europe, and how to prepare robust submissions that meet regulatory expectations.
What you will gain in Part 1:
-
Understand the roles of Reporting Member States (RMS) and Concerned Member States (CMSs).
-
Learn how the assessment process under EU CTR is structured and what it means for your studies.
-
Understand the Clinical Trial Application (CTA) dossier – Part I and Part II.
-
Explore requirements for Investigational Medicinal Products (IMP) and Auxiliary Medicinal Products (AxMP).
-
Build confidence in submission planning and responding effectively to Health Authority Queries.
Why this matters:
By learning these key principles, you’ll build a strong base for working under EU CTR. This will help you handle submissions more smoothly, avoid delays, and manage your trials with greater confidence.
-
40 minutes
Course duration -
-
